Luckily, one company by the name of American Battery Materials, Inc. (OTCMKTS:BLTH) appears well positioned to become a lithium powerhouse due to a jurisdictional and extraction process advantage that allows access to both the US critical mineral supply chain as well as other global markets By now, you may have heard that we are facing […]
Tag: Financial Market
Nano-Cap News Catalyst Watchlist (TBRIF, VOCL, FDCT, GENGF)
Investors are perpetually on the lookout for potential catalysts that can sway stock prices, and news has a proven track record of achieving just that. Positive news can often act as a powerful driver, propelling stocks to new heights. Let’s take a closer look at four such stocks with recent news from this week. Therma […]
OTC Nano-Cap Momentum Watchlist (SWISF, GVXXF, VISM, NHMD)
Savvy investors often use a strategy of identifying stocks that are currently gaining significant momentum. These stocks, known for their impressive price surges, often maintain an upward trajectory over multiple trading sessions, offering potential gains for savvy investors. Now, let’s take a closer look at four stocks that have recently made substantial gains, warranting a […]
OTC Stocks On The Run Watchlist (ORHB, PNXLF, VISM, GEMZ)
Penny stocks on the OTC market have a history of experiencing explosive pops, often triggered by game-changing news or developments. In this investigation, we look at four intriguing OTC penny stocks that may be poised for significant growth as a result of transformative events and opportunities on the horizon. Let’s explore four stocks with recent […]
Non-Small Cell Lung Cancer (NSCLC) Market Anticipating Remarkable Growth by 2032 – DelveInsight | BridgeBio Pharma, Daiichi Sankyo, EMD Serono, Merck, Abbvie, Pfizer, Eli Lilly, BioNTech, Innovent
Delveinsight Business Research LLP As per DelveInsight, the Non-Small Cell Lung Cancer (NSCLC) Market is anticipated to evolve immensely in the coming years owing to the increasing incident cases of NSCLC, continued uptake of approved therapies mainly immune checkpoint inhibitors, expected entry of potential premium price emerging therapies and increasing awareness of mutations, among others. […]
Nano-Cap News Catalysts Watchlist (IMRFF, DBLVF, STAL, FDCFF)
Keeping a keen eye on company announcements can be a prudent strategy for investors, especially when it comes to nano-cap firms. These updates often hold the potential to significantly influence a company’s stock performance. Let’s now explore four nano-cap stocks that could be promising additions to your watchlist, considering their recent updates. iMetal Resources Inc. […]
Prominent Physician and Former Executive, Jose Guethon MD, MBA, CDIP Joins Symbion Coding Inc.
This new partnership aims at improving coding compliance in healthcare. Symbion Coding Inc., a leader in medical coding solutions is thrilled to announce the addition of Dr. Guethon, an accomplished primary care physician and former COO of Metropolitan Health Networks, Inc. and ClareMedica Health Partners LLC to its esteemed team. As a physician advisor and […]
Penny Stocks on the Rise Watchlist (BLTH, WOWI, WRLGF, RAKR)
Savvy investors employ a strategy of tracking momentum in the stock market to secure profits. These are the kinds of stocks that make significant leaps and often maintain their upward trajectory over multiple trading sessions. Now, let’s delve into four stocks that have experienced substantial gains recently, making them prime candidates for your watchlist. American […]
OTC Stocks On The Run Watchlist (SWISF, NHMD, APLIF, ASRE)
Many investors aim to profit from stocks gaining momentum, as these upward-moving stocks can often deliver sustained gains over multiple trading sessions. Let’s explore four stocks that have recently surged in value, making them stocks to watch for potential additions to your watchlist. Sekur Private Data Ltd. (OTC:SWISF) (CSE:SKUR) Sekur Private Data Ltd., a cybersecurity […]
NeurAxis Stock Has 236% Upside Says GSCR Analyst, Fueled By Drug-Free IB-Stim Technology To Treat Pediatric Irritable Bowel Syndrome ($NRXS)
According to an analyst at Goldman Smallcap Research, NeurAxis Inc. (NYSE-Amer: NRXS) shares at current levels present a compelling investment opportunity. In fact, he models for a 12-month price target of $14 a share, roughly 236% higher than its current $4.16. That may not be an overly ambitious target, either. NRXS has only about 1.21 million shares outstanding, […]